← Back to VRTX

VERTEX PHARMACEUTICALS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 06/05/2025
$3,334$2,987$3,076$2,965$2,770$2,772$2,646$2,691
$1,100$1,031$1,083$1,033$646$1,045−$3,594$1,100
$4.31$4.02$4.20$3.99$2.49$4.01−$13.92$4.21
255256258259260261258261

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.